
USFDA APPLICATION NUMBER - 202971 / DOSAGE - FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 300MG/VIAL
Inactive Ingredients
| Ingredient Name | Otsuka America Pharmaceutical, Inc. |
|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED(K679OBS311) | |
| MANNITOL(3OWL53L36A) | |
| SODIUM HYDROXIDE(55X04QC32I) | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE(593YOG76RN) | |
| WATER(059QF0KO0R) |